(Total Views: 98)
Posted On: 12/15/2020 1:40:58 PM
Post# of 21188
$RDHL News Article - RedHill's Phase 2/3 COVID-19 Candidate Opaganib Reduces ARDS-Related Blood Clotting in Preclinical Model https://marketwirenews.com/news-releases/redh...51944.html
(0)
(0)
My Twitter: WhyteStocks